Jefferies Downgrades Pharmaceutical Product Development (PPDI) to Hold
Tweet
Share
E-mailGet Alerts PPDI Hot Sheet
Price: $33.24 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Jefferies downgraded Pharmaceutical Product Development (NASDAQ: PPDI) from Buy to Hold with a price target of $33.25 (down from $35).
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Shares of Pharmaceutical Product Development closed at $33.12 yesterday.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Shares of Pharmaceutical Product Development closed at $33.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
- ICICI Securities Downgrades Landmark Cars (LANDMARK:IN) to Add (2)
- Piper Sandler Downgrades Accelerant Holdings (ARX) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
